Cargando…
PB2024: PREVALENCE OF TYPE 1 GAUCHER DISEASE IN PATIENTS WITH MULTIPLE MYELOMA: FIRST INTERIM ANALYSIS OF A PROSPECTIVE, MULTICENTER, OBSERVATIONAL STUDY
| Autores principales: | , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9431414/ http://dx.doi.org/10.1097/01.HS9.0000850928.87639.6b |
| _version_ | 1784780048588341248 |
|---|---|
| author | Offidani, M. Zizzo, C. Rupoli, S. Federici, I. Bossi, A. Morè, S. Manieri, V. M. Petrucci, M. T. Caravita di Toritto, T. Brunori, M. Gozzetti, A. Tordi, A. Fazio, F. Lisi, C. Morsia, E. Corvatta, L. Olivieri, A. Duro, G. |
| author_facet | Offidani, M. Zizzo, C. Rupoli, S. Federici, I. Bossi, A. Morè, S. Manieri, V. M. Petrucci, M. T. Caravita di Toritto, T. Brunori, M. Gozzetti, A. Tordi, A. Fazio, F. Lisi, C. Morsia, E. Corvatta, L. Olivieri, A. Duro, G. |
| author_sort | Offidani, M. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9431414 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-94314142022-08-31 PB2024: PREVALENCE OF TYPE 1 GAUCHER DISEASE IN PATIENTS WITH MULTIPLE MYELOMA: FIRST INTERIM ANALYSIS OF A PROSPECTIVE, MULTICENTER, OBSERVATIONAL STUDY Offidani, M. Zizzo, C. Rupoli, S. Federici, I. Bossi, A. Morè, S. Manieri, V. M. Petrucci, M. T. Caravita di Toritto, T. Brunori, M. Gozzetti, A. Tordi, A. Fazio, F. Lisi, C. Morsia, E. Corvatta, L. Olivieri, A. Duro, G. Hemasphere Publication Only Lippincott Williams & Wilkins 2022-06-23 /pmc/articles/PMC9431414/ http://dx.doi.org/10.1097/01.HS9.0000850928.87639.6b Text en Copyright © 2022 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
| spellingShingle | Publication Only Offidani, M. Zizzo, C. Rupoli, S. Federici, I. Bossi, A. Morè, S. Manieri, V. M. Petrucci, M. T. Caravita di Toritto, T. Brunori, M. Gozzetti, A. Tordi, A. Fazio, F. Lisi, C. Morsia, E. Corvatta, L. Olivieri, A. Duro, G. PB2024: PREVALENCE OF TYPE 1 GAUCHER DISEASE IN PATIENTS WITH MULTIPLE MYELOMA: FIRST INTERIM ANALYSIS OF A PROSPECTIVE, MULTICENTER, OBSERVATIONAL STUDY |
| title | PB2024: PREVALENCE OF TYPE 1 GAUCHER DISEASE IN PATIENTS WITH MULTIPLE MYELOMA: FIRST INTERIM ANALYSIS OF A PROSPECTIVE, MULTICENTER, OBSERVATIONAL STUDY |
| title_full | PB2024: PREVALENCE OF TYPE 1 GAUCHER DISEASE IN PATIENTS WITH MULTIPLE MYELOMA: FIRST INTERIM ANALYSIS OF A PROSPECTIVE, MULTICENTER, OBSERVATIONAL STUDY |
| title_fullStr | PB2024: PREVALENCE OF TYPE 1 GAUCHER DISEASE IN PATIENTS WITH MULTIPLE MYELOMA: FIRST INTERIM ANALYSIS OF A PROSPECTIVE, MULTICENTER, OBSERVATIONAL STUDY |
| title_full_unstemmed | PB2024: PREVALENCE OF TYPE 1 GAUCHER DISEASE IN PATIENTS WITH MULTIPLE MYELOMA: FIRST INTERIM ANALYSIS OF A PROSPECTIVE, MULTICENTER, OBSERVATIONAL STUDY |
| title_short | PB2024: PREVALENCE OF TYPE 1 GAUCHER DISEASE IN PATIENTS WITH MULTIPLE MYELOMA: FIRST INTERIM ANALYSIS OF A PROSPECTIVE, MULTICENTER, OBSERVATIONAL STUDY |
| title_sort | pb2024: prevalence of type 1 gaucher disease in patients with multiple myeloma: first interim analysis of a prospective, multicenter, observational study |
| topic | Publication Only |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9431414/ http://dx.doi.org/10.1097/01.HS9.0000850928.87639.6b |
| work_keys_str_mv | AT offidanim pb2024prevalenceoftype1gaucherdiseaseinpatientswithmultiplemyelomafirstinterimanalysisofaprospectivemulticenterobservationalstudy AT zizzoc pb2024prevalenceoftype1gaucherdiseaseinpatientswithmultiplemyelomafirstinterimanalysisofaprospectivemulticenterobservationalstudy AT rupolis pb2024prevalenceoftype1gaucherdiseaseinpatientswithmultiplemyelomafirstinterimanalysisofaprospectivemulticenterobservationalstudy AT federicii pb2024prevalenceoftype1gaucherdiseaseinpatientswithmultiplemyelomafirstinterimanalysisofaprospectivemulticenterobservationalstudy AT bossia pb2024prevalenceoftype1gaucherdiseaseinpatientswithmultiplemyelomafirstinterimanalysisofaprospectivemulticenterobservationalstudy AT mores pb2024prevalenceoftype1gaucherdiseaseinpatientswithmultiplemyelomafirstinterimanalysisofaprospectivemulticenterobservationalstudy AT manierivm pb2024prevalenceoftype1gaucherdiseaseinpatientswithmultiplemyelomafirstinterimanalysisofaprospectivemulticenterobservationalstudy AT petruccimt pb2024prevalenceoftype1gaucherdiseaseinpatientswithmultiplemyelomafirstinterimanalysisofaprospectivemulticenterobservationalstudy AT caravitaditorittot pb2024prevalenceoftype1gaucherdiseaseinpatientswithmultiplemyelomafirstinterimanalysisofaprospectivemulticenterobservationalstudy AT brunorim pb2024prevalenceoftype1gaucherdiseaseinpatientswithmultiplemyelomafirstinterimanalysisofaprospectivemulticenterobservationalstudy AT gozzettia pb2024prevalenceoftype1gaucherdiseaseinpatientswithmultiplemyelomafirstinterimanalysisofaprospectivemulticenterobservationalstudy AT tordia pb2024prevalenceoftype1gaucherdiseaseinpatientswithmultiplemyelomafirstinterimanalysisofaprospectivemulticenterobservationalstudy AT faziof pb2024prevalenceoftype1gaucherdiseaseinpatientswithmultiplemyelomafirstinterimanalysisofaprospectivemulticenterobservationalstudy AT lisic pb2024prevalenceoftype1gaucherdiseaseinpatientswithmultiplemyelomafirstinterimanalysisofaprospectivemulticenterobservationalstudy AT morsiae pb2024prevalenceoftype1gaucherdiseaseinpatientswithmultiplemyelomafirstinterimanalysisofaprospectivemulticenterobservationalstudy AT corvattal pb2024prevalenceoftype1gaucherdiseaseinpatientswithmultiplemyelomafirstinterimanalysisofaprospectivemulticenterobservationalstudy AT olivieria pb2024prevalenceoftype1gaucherdiseaseinpatientswithmultiplemyelomafirstinterimanalysisofaprospectivemulticenterobservationalstudy AT durog pb2024prevalenceoftype1gaucherdiseaseinpatientswithmultiplemyelomafirstinterimanalysisofaprospectivemulticenterobservationalstudy |